Skip to main content
. 2023 Dec 21;13(12):e12312. doi: 10.1002/clt2.12312

TABLE 5.

Randomized controlled primary intervention trials for egg allergy.

Study name Population Form of egg Dose Primary outcome Main result Reference
STAR 86 infants with moderate‐to‐severe eczema Pasteurized raw egg powder 0.9 g of egg protein per day Egg allergy on oral challenge and positive SPT to egg A non‐significant reduction of IgE mediated egg allergy in the egg group compared with the control group 94
EAT 1303 infants from general population Cooked egg (together with 5 other types of allergens) 2 g/week Food allergy following oral food challenge Intention‐to‐treat analysis: a non‐significant reduction of egg allergy in the early introduction group.Per‐protocol analysis: a Significant reduction of egg allergy in the early introduction group. 97
STEP 820 infants with hereditary risk Pasteurized raw whole egg powder 0.4 g of egg protein per day Egg allergy on oral challenge and positive SPT to egg A non‐significant reduction of IgE mediated egg allergy in the egg group compared with the control group 93
BEAT 319 infants with hereditary risk Pasteurized raw whole egg powder 0.35 g of egg protein per day Sensitization to white egg based on SPT A reduction in the proportion of infants sensitized to EW in the egg group compared with the control group 92
HEAP 380 infants from general population Pasteurized EW powder 2.5 g per week, 3 times a week (equivalent to 0.83 g of egg protein 3 times a week) Sensitization to hen's egg, based on increased specific serum IgE levels A non‐significant augmentation of egg sensitized infants in the egg group 96
PETIT 147 infants with eczema Heated egg powder 50 mg of heated egg powder (equivalent to 25 mg of egg protein and 0.2 g of boiled egg), then 250 mg per day of egg powder Egg allergy on oral food challenge A significant reduction of egg allergies in the egg group compared with the control group 95

Abbreviation: EW, egg white.